Albany Molecular Research Inc
AMRI
AMRI was delisted on the 31st of August, 2017.
143 hedge funds and large institutions have $669M invested in Albany Molecular Research Inc in 2014 Q3 according to their latest regulatory filings, with 25 funds opening new positions, 46 increasing their positions, 42 reducing their positions, and 14 closing their positions.
100% more funds holding in top 10
Funds holding in top 10: 2 → 4 (+2)
85% more call options, than puts
Call options by funds: $1.95M | Put options by funds: $1.05M
79% more first-time investments, than exits
New positions opened: 25 | Existing positions closed: 14
22% more capital invested
Capital invested by funds: $548M → $669M (+$122M)
8% more funds holding
Funds holding: 132 → 143 (+11)
10% more repeat investments, than reductions
Existing positions increased: 46 | Existing positions reduced: 42
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$19.3M |
| 2 |
BM
Bridger Management
New York
|
+$16.7M |
| 3 |
WIC
Wood Investment Counsel
Denver,
Colorado
|
+$15M |
| 4 |
PIP
Permian Investment Partners
Dallas,
Texas
|
+$14.1M |
| 5 |
HM
HealthCor Management
New York
|
+$10.8M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VAM
Visium Asset Management
New York
|
-$19.9M |
| 2 |
Renaissance Technologies
New York
|
-$7.59M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
-$6.79M |
| 4 |
DCM
Decade Capital Management
New York
|
-$5.3M |
| 5 |
DS
DRW Securities
Chicago,
Illinois
|
-$4.22M |
AMRI Hedge Fund Activity: Q3 2014 in Review
143 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in Albany Molecular Research Inc (AMRI) for Q3 2014, worth a combined $669M — up 22% from $548M a quarter earlier.
Buyers outnumbered sellers: 25 funds opened new AMRI positions and 14 closed out — a net gain of 11 holders — while 46 added to existing stakes and 42 trimmed.
The largest buyer was Morgan Stanley, adding an estimated $19.3M. The largest seller was Visium Asset Management, cutting an estimated $19.9M.
- 143 institutional investors held Albany Molecular Research Inc (AMRI) as of Q3 2014, up from 132 in Q2 2014.
- Funds reported $669M of Albany Molecular Research Inc stock for Q3 2014, up 22% quarter-over-quarter.
- 25 funds opened new Albany Molecular Research Inc positions in Q3 2014 and 14 closed out, a net change of +11 holders.
- The largest Albany Molecular Research Inc buyer in Q3 2014 was Morgan Stanley, an estimated $19.3M added.
- The largest Albany Molecular Research Inc seller in Q3 2014 was Visium Asset Management, an estimated $19.9M sold.
Based on aggregated 13F filings for Q3 2014.